{"id":219080,"date":"2020-05-14T12:40:34","date_gmt":"2020-05-14T16:40:34","guid":{"rendered":"https:\/\/oncubanews.com\/en\/?p=219080"},"modified":"2020-05-14T12:40:34","modified_gmt":"2020-05-14T16:40:34","slug":"cuba-uses-monoclonal-antibody-to-control-cytokine-storm-in-covid-19-patients","status":"publish","type":"post","link":"https:\/\/oncubanews.com\/en\/cuba\/cuba-uses-monoclonal-antibody-to-control-cytokine-storm-in-covid-19-patients\/","title":{"rendered":"Cuba uses monoclonal antibody to control \u201ccytokine storm\u201d in COVID-19 patients"},"content":{"rendered":"<p>Cuba is using the humanized monoclonal antibody Itolizumab within the <a href=\"https:\/\/oncubanews.com\/tag\/coronavirus\/\" target=\"_blank\" rel=\"noopener noreferrer\">COVID-19<\/a> protocol for patients\u2019 medical care to stop the so-called \u201ccytokine storm,\u201d an uncontrolled reaction of the immune system that can have fatal consequences.<\/p>\n<p>The drug, which is commonly used to treat other conditions such as psoriasis and rheumatoid arthritis, has been used in 70 patients from nine Cuban hospitals, the director of Clinical Investigations of Cuba\u2019s Molecular Immunology Center (CIM), Tania Crombet, <a href=\"http:\/\/www.granma.cu\/cuba-covid-19\/2020-05-11\/anticuerpo-monoclonal-itolizumab-hace-su-aporte-contra-la-covid-19-11-05-2020-23-05-55\" target=\"_blank\" rel=\"noopener noreferrer\">affirmed<\/a> to the daily <em>Granma<\/em>.<\/p>\n<p>\u201cIt has been used in patients classified as critical, serious and care, with a high risk of aggravation. The best results have been seen in critically and seriously ill patients,\u201d assured the doctor.<\/p>\n<p>Scientific studies have linked this \u201ccytokine storm\u201d with hyper inflammation and the appearance of acute respiratory failure syndrome or adult respiratory distress syndrome (ARDS), which has been described as the leading cause of COVID-19 mortality.<\/p>\n<p>The director of Clinical Investigations of the CIM, belonging to the BioCubaFarma Business Group, explained in the interview that the drug \u201ccan reduce the secretion of a group of mediators of the inflammation, known as pro-inflammatory cytokines.\u201d<\/p>\n<p>This, according to the specialist, would ultimately allow \u201cstopping in time\u201d the consequences of the cytokine storm, a potentially deadly defensive immune reaction.<\/p>\n<blockquote class=\"wp-embedded-content\" data-secret=\"ig8717L5sw\"><p><a href=\"https:\/\/oncubanews.com\/cuba\/coronavirus-mas-de-cinco-mil-personas-tratadas-en-cuba-con-la-biomodulina-t\/\">Coronavirus: M\u00e1s de cinco mil personas tratadas en Cuba con la Biomodulina T<\/a><\/p><\/blockquote>\n<p><iframe loading=\"lazy\" class=\"wp-embedded-content\" sandbox=\"allow-scripts\" security=\"restricted\" style=\"position: absolute; clip: rect(1px, 1px, 1px, 1px);\" title=\"\u00abCoronavirus: M\u00e1s de cinco mil personas tratadas en Cuba con la Biomodulina T\u00bb \u2014 OnCubaNews\" src=\"https:\/\/oncubanews.com\/cuba\/coronavirus-mas-de-cinco-mil-personas-tratadas-en-cuba-con-la-biomodulina-t\/embed\/#?secret=fRTN6g6lxm#?secret=ig8717L5sw\" data-secret=\"ig8717L5sw\" width=\"500\" height=\"282\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\"><\/iframe><\/p>\n<p>\u201cItolizumab works in the phase of the disease where the damage is caused by the exaggerated response of the immune system to the enormous capacity of the virus to divide,\u201d said the specialist.<\/p>\n<p>She also assured that there are \u201cclinical and imaging evidence of improvement of respiratory distress\u201d in patients.<\/p>\n<p>Dr. Crombet clarified that her team is immersed \u201cin the data collection and interpretation stage, in order to draw definitive conclusions.\u201d<\/p>\n<p>Itolizumab, produced in Cuba since 2014, obtained that same year one of the National Awards of the Cuban Academy of Sciences, and in 2015 it was recognized with the Gold Medal of the World Intellectual Property Organization (WIPO), according to <em>Granma<\/em>.<\/p>\n<p>The company Biocon is also developing and producing this drug in India, where it is mainly used to treat psoriasis patients, although its efficacy in combating coronavirus has also started being tested.<\/p>\n<p>The coronavirus has so far left 1,804 infected in Cuba, 78 deceased and 1,277 recovered.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Cuba is using the humanized monoclonal antibody Itolizumab within the COVID-19 protocol for patients\u2019 medical care to stop the so-called \u201ccytokine storm,\u201d an uncontrolled reaction of the immune system that can have fatal consequences. The drug, which is commonly used to treat other conditions such as psoriasis and rheumatoid arthritis, has been used in 70 [&hellip;]<\/p>\n","protected":false},"author":3606,"featured_media":219081,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[13902],"tags":[29532,15273],"ppma_author":[33548,17270],"class_list":["post-219080","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cuba","tag-coronavirus-in-cuba","tag-cuban-science"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Cuba uses monoclonal antibody to control \u201ccytokine storm\u201d in COVID-19 patients | OnCubaNews English<\/title>\n<meta name=\"description\" content=\"The drug, which is commonly used to treat other conditions such as psoriasis and rheumatoid arthritis, has been used in 70 patients from nine hospitals on the island.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/oncubanews.com\/en\/cuba\/cuba-uses-monoclonal-antibody-to-control-cytokine-storm-in-covid-19-patients\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cuba uses monoclonal antibody to control \u201ccytokine storm\u201d in COVID-19 patients | OnCubaNews English\" \/>\n<meta property=\"og:description\" content=\"The drug, which is commonly used to treat other conditions such as psoriasis and rheumatoid arthritis, has been used in 70 patients from nine hospitals on the island.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/oncubanews.com\/en\/cuba\/cuba-uses-monoclonal-antibody-to-control-cytokine-storm-in-covid-19-patients\/\" \/>\n<meta property=\"og:site_name\" content=\"OnCubaNews English\" \/>\n<meta property=\"article:published_time\" content=\"2020-05-14T16:40:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/oncubanews.com\/en\/wp-content\/uploads\/2020\/05\/f0169121-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"700\" \/>\n\t<meta property=\"og:image:height\" content=\"420\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"EFE, EFE\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"EFE\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/cuba\\\/cuba-uses-monoclonal-antibody-to-control-cytokine-storm-in-covid-19-patients\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/cuba\\\/cuba-uses-monoclonal-antibody-to-control-cytokine-storm-in-covid-19-patients\\\/\"},\"author\":{\"name\":\"EFE\",\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/#\\\/schema\\\/person\\\/4a4376ef86616685852e6d895d4d0eea\"},\"headline\":\"Cuba uses monoclonal antibody to control \u201ccytokine storm\u201d in COVID-19 patients\",\"datePublished\":\"2020-05-14T16:40:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/cuba\\\/cuba-uses-monoclonal-antibody-to-control-cytokine-storm-in-covid-19-patients\\\/\"},\"wordCount\":376,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/cuba\\\/cuba-uses-monoclonal-antibody-to-control-cytokine-storm-in-covid-19-patients\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/wp-content\\\/uploads\\\/2020\\\/05\\\/f0169121-1.jpg\",\"keywords\":[\"coronavirus in Cuba\",\"Cuban science\"],\"articleSection\":[\"Cuba\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/oncubanews.com\\\/en\\\/cuba\\\/cuba-uses-monoclonal-antibody-to-control-cytokine-storm-in-covid-19-patients\\\/#respond\"]}],\"copyrightYear\":\"2020\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/cuba\\\/cuba-uses-monoclonal-antibody-to-control-cytokine-storm-in-covid-19-patients\\\/\",\"url\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/cuba\\\/cuba-uses-monoclonal-antibody-to-control-cytokine-storm-in-covid-19-patients\\\/\",\"name\":\"Cuba uses monoclonal antibody to control \u201ccytokine storm\u201d in COVID-19 patients | OnCubaNews English\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/cuba\\\/cuba-uses-monoclonal-antibody-to-control-cytokine-storm-in-covid-19-patients\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/cuba\\\/cuba-uses-monoclonal-antibody-to-control-cytokine-storm-in-covid-19-patients\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/wp-content\\\/uploads\\\/2020\\\/05\\\/f0169121-1.jpg\",\"datePublished\":\"2020-05-14T16:40:34+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/#\\\/schema\\\/person\\\/4a4376ef86616685852e6d895d4d0eea\"},\"description\":\"The drug, which is commonly used to treat other conditions such as psoriasis and rheumatoid arthritis, has been used in 70 patients from nine hospitals on the island.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/cuba\\\/cuba-uses-monoclonal-antibody-to-control-cytokine-storm-in-covid-19-patients\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/oncubanews.com\\\/en\\\/cuba\\\/cuba-uses-monoclonal-antibody-to-control-cytokine-storm-in-covid-19-patients\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/cuba\\\/cuba-uses-monoclonal-antibody-to-control-cytokine-storm-in-covid-19-patients\\\/#primaryimage\",\"url\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/wp-content\\\/uploads\\\/2020\\\/05\\\/f0169121-1.jpg\",\"contentUrl\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/wp-content\\\/uploads\\\/2020\\\/05\\\/f0169121-1.jpg\",\"width\":700,\"height\":420,\"caption\":\"The Cuban drug Itolizumab used in the treatment of COVID-19. Photo: Courtesy of CIM\\\/Granma.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/cuba\\\/cuba-uses-monoclonal-antibody-to-control-cytokine-storm-in-covid-19-patients\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cuba uses monoclonal antibody to control \u201ccytokine storm\u201d in COVID-19 patients\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/\",\"name\":\"OnCubaNews English\",\"description\":\"Revista sobre Cuba\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/#\\\/schema\\\/person\\\/4a4376ef86616685852e6d895d4d0eea\",\"name\":\"EFE\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2a1de33ef07ae580021e92116e205cdb099068c1ff1fdba600b998c78b6347eb?s=96&r=gd23dcd71e12bce3843a7572453d0d981\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2a1de33ef07ae580021e92116e205cdb099068c1ff1fdba600b998c78b6347eb?s=96&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2a1de33ef07ae580021e92116e205cdb099068c1ff1fdba600b998c78b6347eb?s=96&r=g\",\"caption\":\"EFE\"},\"url\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/author\\\/efe\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cuba uses monoclonal antibody to control \u201ccytokine storm\u201d in COVID-19 patients | OnCubaNews English","description":"The drug, which is commonly used to treat other conditions such as psoriasis and rheumatoid arthritis, has been used in 70 patients from nine hospitals on the island.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/oncubanews.com\/en\/cuba\/cuba-uses-monoclonal-antibody-to-control-cytokine-storm-in-covid-19-patients\/","og_locale":"en_US","og_type":"article","og_title":"Cuba uses monoclonal antibody to control \u201ccytokine storm\u201d in COVID-19 patients | OnCubaNews English","og_description":"The drug, which is commonly used to treat other conditions such as psoriasis and rheumatoid arthritis, has been used in 70 patients from nine hospitals on the island.","og_url":"https:\/\/oncubanews.com\/en\/cuba\/cuba-uses-monoclonal-antibody-to-control-cytokine-storm-in-covid-19-patients\/","og_site_name":"OnCubaNews English","article_published_time":"2020-05-14T16:40:34+00:00","og_image":[{"width":700,"height":420,"url":"https:\/\/oncubanews.com\/en\/wp-content\/uploads\/2020\/05\/f0169121-1.jpg","type":"image\/jpeg"}],"author":"EFE, EFE","twitter_card":"summary_large_image","twitter_misc":{"Written by":"EFE","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/oncubanews.com\/en\/cuba\/cuba-uses-monoclonal-antibody-to-control-cytokine-storm-in-covid-19-patients\/#article","isPartOf":{"@id":"https:\/\/oncubanews.com\/en\/cuba\/cuba-uses-monoclonal-antibody-to-control-cytokine-storm-in-covid-19-patients\/"},"author":{"name":"EFE","@id":"https:\/\/oncubanews.com\/en\/#\/schema\/person\/4a4376ef86616685852e6d895d4d0eea"},"headline":"Cuba uses monoclonal antibody to control \u201ccytokine storm\u201d in COVID-19 patients","datePublished":"2020-05-14T16:40:34+00:00","mainEntityOfPage":{"@id":"https:\/\/oncubanews.com\/en\/cuba\/cuba-uses-monoclonal-antibody-to-control-cytokine-storm-in-covid-19-patients\/"},"wordCount":376,"commentCount":0,"image":{"@id":"https:\/\/oncubanews.com\/en\/cuba\/cuba-uses-monoclonal-antibody-to-control-cytokine-storm-in-covid-19-patients\/#primaryimage"},"thumbnailUrl":"https:\/\/oncubanews.com\/en\/wp-content\/uploads\/2020\/05\/f0169121-1.jpg","keywords":["coronavirus in Cuba","Cuban science"],"articleSection":["Cuba"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/oncubanews.com\/en\/cuba\/cuba-uses-monoclonal-antibody-to-control-cytokine-storm-in-covid-19-patients\/#respond"]}],"copyrightYear":"2020","copyrightHolder":{"@id":"https:\/\/oncubanews.com\/en\/#organization"}},{"@type":"WebPage","@id":"https:\/\/oncubanews.com\/en\/cuba\/cuba-uses-monoclonal-antibody-to-control-cytokine-storm-in-covid-19-patients\/","url":"https:\/\/oncubanews.com\/en\/cuba\/cuba-uses-monoclonal-antibody-to-control-cytokine-storm-in-covid-19-patients\/","name":"Cuba uses monoclonal antibody to control \u201ccytokine storm\u201d in COVID-19 patients | OnCubaNews English","isPartOf":{"@id":"https:\/\/oncubanews.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/oncubanews.com\/en\/cuba\/cuba-uses-monoclonal-antibody-to-control-cytokine-storm-in-covid-19-patients\/#primaryimage"},"image":{"@id":"https:\/\/oncubanews.com\/en\/cuba\/cuba-uses-monoclonal-antibody-to-control-cytokine-storm-in-covid-19-patients\/#primaryimage"},"thumbnailUrl":"https:\/\/oncubanews.com\/en\/wp-content\/uploads\/2020\/05\/f0169121-1.jpg","datePublished":"2020-05-14T16:40:34+00:00","author":{"@id":"https:\/\/oncubanews.com\/en\/#\/schema\/person\/4a4376ef86616685852e6d895d4d0eea"},"description":"The drug, which is commonly used to treat other conditions such as psoriasis and rheumatoid arthritis, has been used in 70 patients from nine hospitals on the island.","breadcrumb":{"@id":"https:\/\/oncubanews.com\/en\/cuba\/cuba-uses-monoclonal-antibody-to-control-cytokine-storm-in-covid-19-patients\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/oncubanews.com\/en\/cuba\/cuba-uses-monoclonal-antibody-to-control-cytokine-storm-in-covid-19-patients\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/oncubanews.com\/en\/cuba\/cuba-uses-monoclonal-antibody-to-control-cytokine-storm-in-covid-19-patients\/#primaryimage","url":"https:\/\/oncubanews.com\/en\/wp-content\/uploads\/2020\/05\/f0169121-1.jpg","contentUrl":"https:\/\/oncubanews.com\/en\/wp-content\/uploads\/2020\/05\/f0169121-1.jpg","width":700,"height":420,"caption":"The Cuban drug Itolizumab used in the treatment of COVID-19. Photo: Courtesy of CIM\/Granma."},{"@type":"BreadcrumbList","@id":"https:\/\/oncubanews.com\/en\/cuba\/cuba-uses-monoclonal-antibody-to-control-cytokine-storm-in-covid-19-patients\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/oncubanews.com\/en\/"},{"@type":"ListItem","position":2,"name":"Cuba uses monoclonal antibody to control \u201ccytokine storm\u201d in COVID-19 patients"}]},{"@type":"WebSite","@id":"https:\/\/oncubanews.com\/en\/#website","url":"https:\/\/oncubanews.com\/en\/","name":"OnCubaNews English","description":"Revista sobre Cuba","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/oncubanews.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/oncubanews.com\/en\/#\/schema\/person\/4a4376ef86616685852e6d895d4d0eea","name":"EFE","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/2a1de33ef07ae580021e92116e205cdb099068c1ff1fdba600b998c78b6347eb?s=96&r=gd23dcd71e12bce3843a7572453d0d981","url":"https:\/\/secure.gravatar.com\/avatar\/2a1de33ef07ae580021e92116e205cdb099068c1ff1fdba600b998c78b6347eb?s=96&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/2a1de33ef07ae580021e92116e205cdb099068c1ff1fdba600b998c78b6347eb?s=96&r=g","caption":"EFE"},"url":"https:\/\/oncubanews.com\/en\/author\/efe\/"}]}},"authors":[{"term_id":33548,"user_id":3606,"is_guest":0,"slug":"efe","display_name":"EFE","avatar_url":"https:\/\/secure.gravatar.com\/avatar\/2a1de33ef07ae580021e92116e205cdb099068c1ff1fdba600b998c78b6347eb?s=96&r=g","author_category":"","last_name":"","first_name":"EFE","job_title":"","user_url":"","description":""},{"term_id":17270,"user_id":0,"is_guest":1,"slug":"cap-efe","display_name":"EFE","avatar_url":"https:\/\/secure.gravatar.com\/avatar\/?s=96&r=g","author_category":"","last_name":"","first_name":"","job_title":"","user_url":"","description":""}],"_links":{"self":[{"href":"https:\/\/oncubanews.com\/en\/wp-json\/wp\/v2\/posts\/219080","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/oncubanews.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/oncubanews.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/oncubanews.com\/en\/wp-json\/wp\/v2\/users\/3606"}],"replies":[{"embeddable":true,"href":"https:\/\/oncubanews.com\/en\/wp-json\/wp\/v2\/comments?post=219080"}],"version-history":[{"count":0,"href":"https:\/\/oncubanews.com\/en\/wp-json\/wp\/v2\/posts\/219080\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/oncubanews.com\/en\/wp-json\/wp\/v2\/media\/219081"}],"wp:attachment":[{"href":"https:\/\/oncubanews.com\/en\/wp-json\/wp\/v2\/media?parent=219080"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/oncubanews.com\/en\/wp-json\/wp\/v2\/categories?post=219080"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/oncubanews.com\/en\/wp-json\/wp\/v2\/tags?post=219080"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/oncubanews.com\/en\/wp-json\/wp\/v2\/ppma_author?post=219080"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}